Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations-Reference-Cited by-同舟云学术

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations

Published:2016-08-11 Issue:40 Volume:7 Page:65185-65195
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lou Na-Na¹²³,Zhang Xu-Chao²³,Chen Hua-Jun²,Zhou Qing²,Yan Li-Xu⁴,Xie Zhi³,Su Jian³,Chen Zhi-Hong³,Tu Hai-Yan²,Yan Hong-Hong²,Wang Zhen²,Xu Chong-Rui²,Jiang Ben-Yuan²,Wang Bin-Chao²,Bai Xiao-Yan²,Zhong Wen-Zhao²,Wu Yi-Long¹²³,Yang Jin-Ji¹²

Affiliation:

1. Southern Medical University, Guangzhou, 510515, China

2. Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, 510080, China

3. Medical Research Center, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, 510080, China

4. Department of Pathology, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, 510080, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer;JCO Precision Oncology;2024-08

2. Analysis of Clinical Features and Treatment Strategies in Advanced Lung Adenocarcinoma Patients With Acquired ALK Fusion After Resistance of EGFR-TKIs;2024-05-31

3. Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer;Frontiers in Pharmacology;2023-08-29

4. Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies;Chinese Medical Journal;2023-06-27

5. Synthesis and evaluation of sulfonamide derivatives targeting EGFR790M/L858R mutations and ALK rearrangement as anticancer agents;Bioorganic & Medicinal Chemistry;2023-05